Dr. Kiran S Divi is the Director and CEO of Divi’s Laboratories Ltd, a leading manufacturer of generic drugs, since January 2020. Prior to his current role, he gained extensive knowledge and understanding of the pharmaceutical industry, with a focus on the US generic market. He is the son of Dr. Murali K Divi, the founder of the company and one of the richest pharma billionaires in the country with a net worth of USD 9.5 billion.
Dr. Kiran Divi holds a bachelor’s degree in Pharmacy from Mangalore University, a post-graduate degree in Pharmacy from Jawaharlal Nehru Technological University, and a PhD degree from Gandhi Institute of Technology and Management, Visakhapatnam. He has been with Divi’s Laboratories since August 2001 and has played a crucial role in developing high-quality business strategies and plans that align with the company’s short-term and long-term objectives.
As CEO, Dr. Kiran Divi oversees all corporate functions and operations at the manufacturing facilities. He is joined by his sister, Nilima Prasad Divi, who has been the company’s whole-time Director (commercial) since July 2012. Together, the siblings and their father, Dr. Murali K Divi, work together to run the company, which has a market cap of over Rs 1.55 lakh crore as of March 19. Under Dr. Kiran’s leadership, the company has achieved significant milestones and is well-positioned for continued growth and success in the pharmaceutical industry.